Cargando…

Comparison of first versus second line sacrocolpopexies in terms of morbidity and mid-term efficacy

To compare pelvic organ prolapse (POP) recurrence and morbidity between first and second line sacrocolpopexies. We conducted a retrospective chart review of all laparoscopic or robotic sacrocolpopexies for POP-Q stage ≥ 2, with or without a history of previous prolapse repair, performed with a simil...

Descripción completa

Detalles Bibliográficos
Autores principales: Lallemant, Marine, Grob, A. T. M., Puyraveau, M., Perik, M. A. G., Alhafidh, A. H. H., Cosson, M., Ramanah, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522651/
https://www.ncbi.nlm.nih.gov/pubmed/36175515
http://dx.doi.org/10.1038/s41598-022-20127-5
_version_ 1784800106120216576
author Lallemant, Marine
Grob, A. T. M.
Puyraveau, M.
Perik, M. A. G.
Alhafidh, A. H. H.
Cosson, M.
Ramanah, R.
author_facet Lallemant, Marine
Grob, A. T. M.
Puyraveau, M.
Perik, M. A. G.
Alhafidh, A. H. H.
Cosson, M.
Ramanah, R.
author_sort Lallemant, Marine
collection PubMed
description To compare pelvic organ prolapse (POP) recurrence and morbidity between first and second line sacrocolpopexies. We conducted a retrospective chart review of all laparoscopic or robotic sacrocolpopexies for POP-Q stage ≥ 2, with or without a history of previous prolapse repair, performed with a similar technique between January 2012 and June 2019 in 3 European Gynecologic Surgery Departments. Patients were separated into two groups: first line sacrocolpopexy (FLS) and second line sacrocolpopexy (SLS). Each patient from the SLS group was age-matched with a patient from the FLS group. The primary outcome measure was reoperation procedures for recurrent POP defined as a symptomatic POP-Q stage ≥ 2 POP in at least one vaginal compartment. Secondary outcomes included operative time, intraoperative organ trauma, intraoperative blood loss, postoperative POP recurrence (operated on or not), global reoperation and mesh-related complications. During this period, 332 patients were included. After age-matching, 170 patients were analyzed: 85 patients in the FLS and SLS groups, respectively. After a mean follow-up of 3 years, there was no statistically significant difference between the two groups in terms of recurrent POP (9.4% versus 10.6%, p = 0.7), recurrent POP reoperation (3.5% versus 5.9% p = 0.7), mesh-related reoperation (0% versus 2.4%, p = 0.5), global reoperation (3.5 versus 8.2%, p = 0.3), operative time (198 ± 67 min versus 193 ± 60 min, p = 0.5), intraoperative complications such as organ injury (4.7% versus 7.1%, p = 0.7) and blood loss > 500 mL (2.4% versus 0%, p = 0.5). Patients who underwent a first or a second line sacrocolpopexy seemed to have similar rates of prolapse recurrence and complications.
format Online
Article
Text
id pubmed-9522651
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-95226512022-10-01 Comparison of first versus second line sacrocolpopexies in terms of morbidity and mid-term efficacy Lallemant, Marine Grob, A. T. M. Puyraveau, M. Perik, M. A. G. Alhafidh, A. H. H. Cosson, M. Ramanah, R. Sci Rep Article To compare pelvic organ prolapse (POP) recurrence and morbidity between first and second line sacrocolpopexies. We conducted a retrospective chart review of all laparoscopic or robotic sacrocolpopexies for POP-Q stage ≥ 2, with or without a history of previous prolapse repair, performed with a similar technique between January 2012 and June 2019 in 3 European Gynecologic Surgery Departments. Patients were separated into two groups: first line sacrocolpopexy (FLS) and second line sacrocolpopexy (SLS). Each patient from the SLS group was age-matched with a patient from the FLS group. The primary outcome measure was reoperation procedures for recurrent POP defined as a symptomatic POP-Q stage ≥ 2 POP in at least one vaginal compartment. Secondary outcomes included operative time, intraoperative organ trauma, intraoperative blood loss, postoperative POP recurrence (operated on or not), global reoperation and mesh-related complications. During this period, 332 patients were included. After age-matching, 170 patients were analyzed: 85 patients in the FLS and SLS groups, respectively. After a mean follow-up of 3 years, there was no statistically significant difference between the two groups in terms of recurrent POP (9.4% versus 10.6%, p = 0.7), recurrent POP reoperation (3.5% versus 5.9% p = 0.7), mesh-related reoperation (0% versus 2.4%, p = 0.5), global reoperation (3.5 versus 8.2%, p = 0.3), operative time (198 ± 67 min versus 193 ± 60 min, p = 0.5), intraoperative complications such as organ injury (4.7% versus 7.1%, p = 0.7) and blood loss > 500 mL (2.4% versus 0%, p = 0.5). Patients who underwent a first or a second line sacrocolpopexy seemed to have similar rates of prolapse recurrence and complications. Nature Publishing Group UK 2022-09-29 /pmc/articles/PMC9522651/ /pubmed/36175515 http://dx.doi.org/10.1038/s41598-022-20127-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Lallemant, Marine
Grob, A. T. M.
Puyraveau, M.
Perik, M. A. G.
Alhafidh, A. H. H.
Cosson, M.
Ramanah, R.
Comparison of first versus second line sacrocolpopexies in terms of morbidity and mid-term efficacy
title Comparison of first versus second line sacrocolpopexies in terms of morbidity and mid-term efficacy
title_full Comparison of first versus second line sacrocolpopexies in terms of morbidity and mid-term efficacy
title_fullStr Comparison of first versus second line sacrocolpopexies in terms of morbidity and mid-term efficacy
title_full_unstemmed Comparison of first versus second line sacrocolpopexies in terms of morbidity and mid-term efficacy
title_short Comparison of first versus second line sacrocolpopexies in terms of morbidity and mid-term efficacy
title_sort comparison of first versus second line sacrocolpopexies in terms of morbidity and mid-term efficacy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522651/
https://www.ncbi.nlm.nih.gov/pubmed/36175515
http://dx.doi.org/10.1038/s41598-022-20127-5
work_keys_str_mv AT lallemantmarine comparisonoffirstversussecondlinesacrocolpopexiesintermsofmorbidityandmidtermefficacy
AT grobatm comparisonoffirstversussecondlinesacrocolpopexiesintermsofmorbidityandmidtermefficacy
AT puyraveaum comparisonoffirstversussecondlinesacrocolpopexiesintermsofmorbidityandmidtermefficacy
AT perikmag comparisonoffirstversussecondlinesacrocolpopexiesintermsofmorbidityandmidtermefficacy
AT alhafidhahh comparisonoffirstversussecondlinesacrocolpopexiesintermsofmorbidityandmidtermefficacy
AT cossonm comparisonoffirstversussecondlinesacrocolpopexiesintermsofmorbidityandmidtermefficacy
AT ramanahr comparisonoffirstversussecondlinesacrocolpopexiesintermsofmorbidityandmidtermefficacy